Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro

Soheilyfar, 2018, In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer, J. BUON, 23, 1290 Tupal, 2020, Application of ɑ-tocotrienol-loaded biocompatible precirol in attenuation of doxorubicin dose-dependent behavior in HUH-7 hepatocarcinoma cell line, Nutr. Cancer, 72, 653, 10.1080/01635581.2019.1650191 Mohammadian, 2020, Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells, N. Schmied. Arch. Pharmacol., 393, 2315, 10.1007/s00210-020-01942-x Brown, 2021, Metabolic pathways in obesity-related breast cancer, Nat. Rev. Endocrinol., 17, 350, 10.1038/s41574-021-00487-0 Gnant, 2021, Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer, N. Engl. J. Med., 385, 395, 10.1056/NEJMoa2104162 Yousefi, 2021, Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance, Oncogene, 40, 1043, 10.1038/s41388-020-01588-2 Maroufi, 2020, Vascular mimicry: changing the therapeutic paradigms in cancer, Mol. Biol. Rep., 47, 4749, 10.1007/s11033-020-05515-2 Maroufi, 2020, Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism, N. Schmied. Arch. Pharmacol., 393, 1, 10.1007/s00210-019-01692-5 Shabgah, 2021, Curcumin and cancer; are long non-coding RNAs missing link?, Prog. Biophys. Mol. Biol., 164, 63, 10.1016/j.pbiomolbio.2021.04.001 Rahimi, 2021, Curcumin: a dietary phytochemical for targeting the phenotype and function of dendritic cells, Curr. Med. Chem., 28, 1549, 10.2174/0929867327666200515101228 Mohammadian Haftcheshmeh, 2020, Immunomodulatory therapeutic effects of curcumin in rheumatoid arthritis, Autoimmun. Rev., 19, 10.1016/j.autrev.2020.102593 Xu, 2018, Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways, Oncol. Lett., 15, 1931 Niroumand, 2015, Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review, J. Tradit. Chin. Med., 35, 104, 10.1016/S0254-6272(15)30016-9 Birar, 2021, Reaction between harmaline and vanillin to produce dimeric scaffoldsthat exhibit anti-proliferative activity, Tetrahedron Lett., 73, 10.1016/j.tetlet.2021.153139 Chuan, 2012, The effects of soft capsule of herbal pegani total base on sarcoma S180 cells andHepatocellular carcinoma H22, J. Shaanxi Coll. Tradit. Chinese Med. Kunnumakkara, 2014 Zhang, 2021, Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting, mTOR, 35, 6377 Roy, 2020, Discovery of harmaline as a potent inhibitor of sphingosine kinase-1: a chemopreventive role in lung cancer, ACS Omega, 5, 21550, 10.1021/acsomega.0c02165 Ghosh, 2020, In vitro relationship between serum protein binding to beta-carboline alkaloids: a comparative cytotoxic, spectroscopic and calorimetric assays, J. Biomol. Struct. Dynam., 38, 1103, 10.1080/07391102.2019.1595727 Wang, 2015, Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells, Sci. Rep., 5, 10.1038/srep18613 Hashemi Sheikh Shabani, 2015, Peganum harmala L.'s anti-growth effect on a breast cancer cell line, Biotechnol. Rep. (Amsterdam, Netherlands), 8, 138 El Gendy, 2010, Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects, Planta Med., 76, 671, 10.1055/s-0029-1240633 Cao, 2011, Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway, Hepatobiliary Pancreat. Dis. Int., 10, 599, 10.1016/S1499-3872(11)60102-1 Tacar, 2013, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, J. Pharm. Pharmacol., 65, 157, 10.1111/j.2042-7158.2012.01567.x Ahmadian, 2021, 1 Fitzgibbons, 2021, Protocol for the examination of resection specimens from patients with invasive carcinoma of the breast, J. Breast Cancer, 24, 1 Sethi, 2012, Histopathologic changes following neoadjuvant chemotherapy in various malignancies, Int. J. Appl. Basic Med. Res., 2, 111, 10.4103/2229-516X.106353 Ilić, 2019, The Quantitative ER immunohistochemical analysis in breast cancer: detecting the 3+ 0, 4+ 0, and 5+ 0 Allred score cases, Medicina, 55, 461, 10.3390/medicina55080461 Haiaty, 2020, Targeting vasculogenic mimicry by phytochemicals: a potential opportunity for cancer therapy, IUBMB Life, 72, 825, 10.1002/iub.2233 Hajipour, 2018, Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers, Artif. Cell Nanomed. Biotechnol., 46, 283, 10.1080/21691401.2017.1423493 Berrougui, 2006, Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed's in isolated rat aorta, Pharmacol. Res., 54, 150, 10.1016/j.phrs.2006.04.001 Li, 2017, Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells, Phytomedicine, 28, 10, 10.1016/j.phymed.2017.02.008 Uhl, 2018, Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma, Cancer Cell Int., 18, 1, 10.1186/s12935-018-0574-3 Geng, 2018, Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy, Biochem. Biophys. Res. Commun., 498, 99, 10.1016/j.bbrc.2018.02.205 Hyytiäinen, 2021, Angiogenesis inhibitors for head and neck squamous cell carcinoma treatment: is there still hope?, Front. Oncol., 11, 2123, 10.3389/fonc.2021.683570 Kimura, 2021, Comparison of vascular endothelial growth factor/vascular endothelial growth factor receptor 2 expression and its relationship to tumor cell proliferation in canine epithelial and mesenchymal tumors, J. Vet. Med. Sci. Lee, 2020, Soya-cerebroside inhibits VEGF-facilitated angiogenesis in endothelial progenitor cells, Food Agric. Immunol., 31, 193, 10.1080/09540105.2020.1713055 Mezu-Ndubuisi, 2021, The role of integrins in inflammation and angiogenesis, Pediatr. Res., 89, 1619, 10.1038/s41390-020-01177-9 Vahedian, 2020, Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines, Horm. Mol. Biol. Clin. Invest., 41 Liu, 2018, MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma, Mol. Cell. Biochem., 448, 61, 10.1007/s11010-018-3313-0 Ren, 2021, Circ_0000620 acts as an oncogenic factor in gastric cancer through regulating MMP2 expression via sponging miR-671-5p, J. Biol. Res., 28, 23 Kauer, 2019, CD105 (Endoglin) as negative prognostic factor in AML, Sci. Rep., 9, 1, 10.1038/s41598-019-54767-x Nafie, 2021, Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1, PLoS One, 16, 10.1371/journal.pone.0247652 Tang, 2018, New insights into the role of soluble E-cadherin in tumor angiogenesis, Cell stress, 2, 236, 10.15698/cst2018.09.154 Ma, 2020, The expression of AGGF1, FOXC2, and E-cadherin in esophageal carcinoma and their clinical significance, Medicine (Baltim.), 99 Rueff, 2016, 1 Nikolaou, 2018, The challenge of drug resistance in cancer treatment: a current overview, Clin. Exp. Metastasis, 35, 309, 10.1007/s10585-018-9903-0 Park, 2021, Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation, BMB reports, 54, 470, 10.5483/BMBRep.2021.54.9.096 Borgström, 1999, Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin, Anticancer Res., 19, 4203 Li, 2019, Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects, Pharmacol. Res., 146, 10.1016/j.phrs.2019.104313 Uvez, 2020, Synergistic interactions between resveratrol and doxorubicin inhibit angiogenesis both in vitro and in vivo, Pol. J. Vet. Sci., 23, 571 Thorn, 2011, Doxorubicin pathways: pharmacodynamics and adverse effects, Pharmacogenetics Genom., 21, 440, 10.1097/FPC.0b013e32833ffb56